15.05.2014 Views

PATENTS OFFICE JOURNAL - Irish Patents Office

PATENTS OFFICE JOURNAL - Irish Patents Office

PATENTS OFFICE JOURNAL - Irish Patents Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(No. 1985) <strong>Patents</strong> <strong>Office</strong> Journal (14/01/2004) 2642<br />

2001027 PENTECH PHARMACEUTICALS, INC., 417 Harvester Court, Wheeling, IL<br />

60090, United States of America<br />

QUEEN'S UNIVERSITY AT KINGSTON, 76 Stuart Street, Kingston Ontario<br />

K7L 2V7, Canada<br />

04/12/2003<br />

Patent No: 0758895; Sublingual dosage forms containing apomorphine for use in<br />

the treatment of erectile dysfunction<br />

Product: Apomorphine or a pharmaceutically-acceptable acid addition salt<br />

thereof, especially the hydrochloride<br />

Market Authorisation: Ireland EU/1/01/180/001-010, 28/05/2001<br />

European Union EU/1/01/180/001-010, 28/05/2001<br />

Certificate Expires on: 27/05/2016<br />

2001028 KIRIN-AMGEN, INC., 6002 Lucerne (CH), Switzerland<br />

04/12/2003<br />

Patent No: 0640619; Erythropoietin analogs with additional glycosylation sites<br />

Product: Darbepoetin alfa<br />

Market Authorisation: Ireland EU/1/01/185/001-030, 08/06/2001<br />

European Union EU/1/01/185/001-030, 08/06/2001<br />

Certificate Expires on: 07/06/2016<br />

2001029 MERCK & CO., INC., Rahway, New Jersey 07065-9000, United States of<br />

America<br />

04/12/2003<br />

Patent No: 0620232; Aza cyclohexapeptide compounds<br />

Product: Caspofungin, optionally in the form of pharmaceutically acceptable salt,<br />

especially caspofungin acetate.<br />

Market Authorisation: Ireland EU/1/01/196/001-003, 24/10/2001<br />

European Union EU/1/01/196/001-003, 24/10/2001<br />

Certificate Expires on: 23/10/2016<br />

2001030 AVENTIS PHARMA S.A., 102 route de Noisy, F-93235 Romainville Cedex,<br />

France<br />

04/12/2003<br />

Patent No: 0680967; Erythromycin derivatives, their process of preparation and<br />

their use as medicaments<br />

Product: Telithromycin and its pharmaceutically acceptable acid addition salts.<br />

Market Authorisation: Ireland EU/1/01/191/001 - 004, 09/07/2001<br />

European Union EU/1/01/191/001-004, 09/07/2001<br />

Certificate Expires on: 08/07/2016

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!